Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E and Alzheimer disease

W J Strittmatter1, A D Roses

  • 1Department of Medicine (Neurology), Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 27710, USA.

Proceedings of the National Academy of Sciences of the United States of America
|May 23, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyallelic structural variants can provide accurate, highly informative genetic markers focused on diagnosis and therapeutic targets: Accuracy vs. Precision.

Clinical pharmacology and therapeutics·2015
Same author

Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

Translational psychiatry·2014
Same author

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.

Neuromuscular disorders : NMD·2013
Same author

Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions?

Age·2013
Same author

Using genetics to enable studies on the prevention of Alzheimer's disease.

Clinical pharmacology and therapeutics·2012
Same author

A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.

Molecular psychiatry·2012

Apolipoprotein E (apoE) alleles influence Alzheimer's disease risk and onset. ApoE interactions with tau and amyloid beta may explain how different apoE forms contribute to Alzheimer's disease pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) risk and onset are significantly influenced by apolipoprotein E (apoE) alleles.
  • The precise mechanisms by which apoE isoforms contribute to AD pathogenesis remain unclear.

Purpose of the Study:

  • To investigate the role of apoE isoforms in Alzheimer's disease.
  • To explore how apoE interactions with tau and amyloid-beta peptide contribute to disease mechanisms.

Main Methods:

  • Analysis of isoform-specific differences in apoE binding to tau and amyloid beta.
  • Investigation of apoE's presence in neuronal cytoplasm and its binding to microtubule-associated proteins (MAPs).

Main Results:

  • Identified isoform-specific differences in apoE binding to tau and amyloid beta peptide.

Related Experiment Videos

  • Detected apoE in neuronal cytoplasm, suggesting a potential role in microtubule function.

    • Conclusions:

    • Apolipoprotein E's interactions with tau and amyloid beta provide testable hypotheses for AD pathogenesis.
    • ApoE may influence microtubule function in the Alzheimer's brain, linking pathological lesions to cellular pathogenesis and dementia.